Showing Results : 1-1 of 1
Sort By :
  • LATEST MANUSCRIPTS IN Medicine in Drug Discovery
  • Maanaskumar R Gantla, Igor F Tsigelny, Valentina L Kouznetsova. Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning. Medicine in drug discovery. 2023, 17: 100148
    Cited : 6
    Read More
  • Omkar Indari, Ajit Kumar Singh, Deeksha Tiwari, Hem Chandra Jha, Anupam Nath Jha. Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an study. Medicine in drug discovery. 2022, 16: 100146
    Cited : 16
    Read More
  • Sowbarnika Ravichandran, Nivethitha Manickam, Mahesh Kandasamy. Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19. Medicine in drug discovery. 2022, 15: 100136
    Cited : 7
    Read More
  • Praveen Prathapan. A determination of pan-pathogen antimicrobials? Medicine in drug discovery. 2022, 14: 100120
    Cited : 3
    Read More
  • Marcin Delijewski, Jacek Haneczok. AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate. Medicine in drug discovery. 2021, 9: 100077
    Cited : 29
    Read More
  • Gregory Upert, Anatol Luther, Daniel Obrecht, Philipp Ermert. Emerging peptide antibiotics with therapeutic potential. Medicine in drug discovery. 2021, 9: 100078
    Cited : 57
    Read More
  • Tahereh Seifi, Ali Reza Kamali. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Medicine in drug discovery. 2021, 11: 100099
    Cited : 51
    Read More
  • Subham Das, Anu Kunnath Ramachandran, Sumit Raosaheb Birangal, Saleem Akbar, Bahar Ahmed, Alex Joseph. The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review. Medicine in drug discovery. 2021, 10: 100085
    Cited : 17
    Read More
  • Fedaa Ali, Amal Kasry, Muhamed Amin. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant. Medicine in drug discovery. 2021, 10: 100086
    Cited : 152
    Read More
  • Nikky Goel, Razi Ahmad, Huma Fatima, Sunil Kumar Khare. New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic. Medicine in drug discovery. 2021, 10: 100089
    Cited : 13
    Read More
  • Xu Li, Jinchao Yu, Zhiming Zhang, Jing Ren, Alex E Peluffo, Wen Zhang, Yujie Zhao, Jiawei Wu, Kaijing Yan, Daniel Cohen, Wenjia Wang. Network bioinformatics analysis provides insight into drug repurposing for COVID-19. Medicine in drug discovery. 2021, 10: 100090
    Cited : 43
    Read More
  • Shaimaa S Goher, Fedaa Ali, Muhamed Amin. The Delta Variant Mutations in the Receptor Binding Domain of SARS-CoV-2 Show Enhanced Electrostatic Interactions with the ACE2. Medicine in drug discovery. 2021, : 100114
    Cited : 29
    Read More
  • Di Liu, Qiang Wang, Huacai Zhang, Li Cui, Feng Shen, Yong Chen, Jiali Sun, Lebin Gan, Jianhui Sun, Jun Wang, Jing Zhang, Qingli Cai, Jin Deng, Jianxin Jiang, Ling Zeng. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19). Medicine in drug discovery. 2020, 8: 100057
    Cited : 34
    Read More
  • Hanxiao Yu, He Yang, Enxue Shi, Wenjun Tang. Development and Clinical Application of Phosphorus-Containing Drugs. Medicine in drug discovery. 2020, 8: 100063
    Cited : 99
    Read More
  • Cristian Arvinte, Maharaj Singh, Paul E Marik. Serum Levels of Vitamin C and Vitamin D in a Cohort of Critically Ill COVID-19 Patients of a North American Community Hospital Intensive Care Unit in May 2020: A Pilot Study. Medicine in drug discovery. 2020, 8: 100064
    Cited : 91
    Read More
 
 


Journal List
Links
Content Links
About Us

0